664991-82-6Relevant articles and documents
MAP4K4 INHIBITORS
-
Paragraph 00211; 00212, (2019/05/02)
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, f
SUBSTITUTED PYRROLOPYRIDINES
-
Page 55, (2010/11/30)
There are provided novel compounds of formula (I) wherein R1, R2 and R3 are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the kinase Itk.